Platelet count partially mediates the association between mixed metal exposure and atherosclerotic cardiovascular

Li-Jun Li1, Ying Liu2, Jia Wei2

  • 1The Second Affiliated Hospital, School of Public Health, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China; The Key Laboratory of Typical Environmental Pollution and Health Hazards of Hunan Province, School of Public Health, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Insights

Mixed metal exposure, particularly cadmium, strontium, and thallium, increases atherosclerotic cardiovascular disease (ASCVD) risk. Platelet count partially mediates this association, highlighting a novel pathway for ASCVD development.

Area of Science:

  • Environmental Health
  • Cardiovascular Disease Epidemiology
  • Toxicology

Background:

  • Platelets play a known role in atherosclerotic cardiovascular disease (ASCVD).
  • The impact of mixed metal exposure on ASCVD risk and its relationship with platelet count is not well understood.
  • Understanding these interactions is crucial for public health and clinical practice.

Purpose of the Study:

  • To investigate the association between exposure to a mixture of metals and ASCVD risk.
  • To examine the potential mediating role of platelet count (PLT) in the relationship between metal mixtures and ASCVD.
  • To identify specific metals contributing to ASCVD risk through PLT.

Main Methods:

  • Case-control study design.
  • Weighted Quantile Sum (WQS) regression and Bayesian Kernel Machine Regression (BKMR) to analyze plasma metal mixtures and ASCVD risk.
  • LASSO regression and adjusted linear regression to identify key metals and their association with platelet count.
  • Mediation analysis to quantify the role of PLT.

Main Results:

  • A nine-metal mixture was significantly associated with increased ASCVD risk (OR = 1.89).
  • Cadmium (Cd), strontium (Sr), and thallium (Tl) were identified as major contributors to ASCVD risk.
  • Cd, Sr, and Tl were positively associated with platelet count (PLT).
  • PLT partially mediated the association between Cd, Sr, Tl, and ASCVD risk (mediation proportions: 3.7%, 8.4%, 4.9% respectively).

Conclusions:

  • Mixed metal exposure is a significant risk factor for ASCVD.
  • Cadmium, strontium, and thallium are key metals driving this association.
  • Platelet count plays a modest, partial mediating role in the pathway from metal exposure to ASCVD risk.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...